Sartorius Stedim Biotech S.A.
(OTC: SRTOY)
|
2:14 PM UTC, 07/02/24 | |||
---|---|---|---|---|
Last: $15.80 | Change: +0.00 | %Change: +0.00% | Volume: 720 |
Open: | $ 15.80 | Volume: | 720 | |
---|---|---|---|---|
High: | $ 15.80 | Yield(%) | 0.26 | |
Low: | $ 15.80 | P/E Ratio (ttm): | 53.97 | |
Dividend ($): | 0.04 | Market Cap ($): | 15.59B | |
EPS ($) | 0.30 | Shares Out: | 973.15M |
% Price Change (last 4 weeks): | -17.86 |
---|---|
% Price Change (last 13 weeks): | -42.40 |
% Price Change (last 26 weeks): | -41.20 |
% Price Change (last 52 weeks): | -35.76 |
% Price Change (year to date): | -39.45 |
Return on Equity (%): | 12.11 |
---|---|
Return on Assets (%): | 4.79 |
Return on Invested Capital (%): | 19.15 |
Gross Profit Margin (%): | 44.44 |
---|---|
Net Profit Margin (%): | 11.16 |
Operating Profit Margin (%): | 17.46 |
|
|
50-day Moving Average: | $13.09 |
---|---|
200-day Moving Average: | $12.91 |
Avg. Daily Vol. (last 50 days): | 4,721 |
Avg. Daily Vol. (last 200 days): | 2,939 |
52-wk high: | $31.80 |
52-wk low: | $15.80 |
Bid: | $n/a |
Ask: | $n/a |
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm offers a broad portfolio of products that focuses on all steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Its technologies cover inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for storage and transportation. It also offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. The company was founded on September 28, 1978 and is headquartered in Aubagne, France.
|
Sartorius Stedim Biotech S.A.
Zone Industrielle Les Paluds Avenue de Jouques Aubagne PA 13400 Phone: 33.4.42.84.56.00 Fax: 33.4.42.84.56.19 http://www.sartorius.com |
Earnings (1year) ($): | 0.30 |
---|---|
Annual Dividend ($): | 0.04 |
Current P/E Ratio (ttm): | 53.97 |
Book Value ($): | 3.16 |
Cash Flow ($): | 0.64 |
Price/Earnings (x): | 53.97 |
---|---|
Price/Sales (x): | 8.13 |
Price/Book (x): | 8.37 |
Price/Cash Flow (x): | 35.82 |
Quick Ratio (x): | 0.57 |
---|---|
Current Ratio (x): | 1.51 |
LT Debt/Equity (x): | 136.58 |
Total Debt/Equity (x): | 139.58 |